Design and construction of a Bacillus amyloliquefaciens cell factory for hyaluronic acid synthesis from Jerusalem artichoke inulin

• Published in: International journal of biological macromolecules Vol. 205; pp. 410 - 418
• Main Authors: Ma, Yanqin, Qiu, Yibin, Yu, Caiyuan, Li, Sha, Xu, Hong
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 30.04.2022
• Subjects: Bacillus amyloliquefaciens; CRISPR/Cas9n system; Hyaluronic acid; Jerusalem artichoke inulin; Metabolic engineering; Metabolic engineering; Jerusalem artichoke inulin; Bacillus amyloliquefaciens; Hyaluronic acid; CRISPR/Cas9n system
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2022.02.100

Hyaluronic acid (HA), a high-value biomacromolecule, has wide applications in medical, cosmetic and food fields. Currently, employing the safe-grade microorganisms for de novo biosynthesis of HA from renewable substrates has become a promising alternative. In this study, we established a Bacillus amyloliquefaciens strain as platform for HA production from Jerusalem artichoke inulin. Firstly, the different HA and UDP-GlcUA synthase genes were introduced into B. amyloliquefaciens to construct the HA synthesis pathway. Secondly, the byproduct polysaccharides were removed by knocking sacB and epsA-O using CRISPR/Cas9n system, resulting in a 13% increase in HA production. Finally, 2.89 g/L HA with a high molecular weight of 1.5 MDa was obtained after optimizing fermentation conditions and adding osmotic agents. This study demonstrates the engineered B. amyloliquefaciens can effectively synthesize HA with Jerusalem artichoke inulin and provides a green route for HA production.